BioScrip, Inc. (NASDAQ:BIOS)

CAPS Rating: 2 out of 5

The Company provides pharmaceutical and pharmacy benefit management services.

Results 1 - 20 of 22 : 1 2 Next »

Recs

0
Member Avatar JCLscapXperiment (36.67) Submitted: 12/14/2014 6:44:02 PM : Underperform Start Price: $5.92 BIOS Score: -4.88

Jul15 Put $0.75, $5 Strike

Recs

0
Member Avatar rbitrage (69.80) Submitted: 10/14/2014 7:44:59 PM : Underperform Start Price: $6.08 BIOS Score: +7.28

No tangible book value. No earnings or free cash flow over the last year.

Recs

0
Member Avatar vjportlim (46.67) Submitted: 1/23/2014 10:36:19 AM : Outperform Start Price: $8.07 BIOS Score: -34.57

Barron's Roundtable - Schafer

Recs

0
Member Avatar cavemantrader (46.18) Submitted: 11/27/2013 11:24:49 AM : Outperform Start Price: $6.99 BIOS Score: -23.41

BIOS continues to gain market shares, absolutely huge and growing market, revenue increasing, margins now improving, even a nice chance of a buyout exists is icing on the cake. Very good buy on a valuation basis.

Recs

0
Member Avatar rocknpopstocks (< 20) Submitted: 1/20/2011 12:02:13 PM : Outperform Start Price: $5.01 BIOS Score: -35.41

Should see strong play as the market picks back up.

Recs

0
Member Avatar 21popsontop (< 20) Submitted: 12/1/2010 1:43:18 PM : Outperform Start Price: $4.48 BIOS Score: -29.13

Longshots under $5 screen.

Recs

0
Member Avatar franktejon (< 20) Submitted: 11/3/2010 6:03:48 AM : Outperform Start Price: $4.49 BIOS Score: -31.49

strong buy at $2.00

Recs

0
Member Avatar dynam000 (< 20) Submitted: 9/22/2010 1:49:00 PM : Outperform Start Price: $5.27 BIOS Score: -61.90

CHS acquisition to assist with revenue and earnings growth. Fairly priced today, but has potential to outperform once all acquisition operational issues are resolved.

Recs

3
Member Avatar cbierbaum (90.81) Submitted: 11/4/2009 8:50:47 PM : Outperform Start Price: $7.72 BIOS Score: -113.84

BIOS has begun to cut necessary overhead reaching critical mass and positive operating leverage. According to an analysis conducted by Kaiser Permanente most payors contract with more than one specialty pharmacy management company and view cost containment in this space a priority. This should allow for ample opportunities to gain market share from leaders ESRX, MHS and ABC. With a strong biologic pipeline with many drugs competing in the same care class, the need for specialty pharmacy, DM, PBM and distributions services is set to be robust for the foreseeable future. Given that Part B is largely unaffected by healthcare reform proposals, I believe that an increase in covered lives and underlying secular trends for biotherapeutics will allow BIOS to outperform the market for some time to come. When evaluating precedent transactions, both public and private, in the specialty pharmacy/distribution space, and backing into an intrinsic EV/EBITDA multiple, I find that BIOS, now that operating and management issues are being smoothed out, has the potential to trade between 18-21x forward EBITDA.

Recs

0
Member Avatar TheDoughMaker (57.77) Submitted: 6/11/2009 10:51:20 AM : Outperform Start Price: $4.45 BIOS Score: -78.50

Excellent Takeover Candidate!

Recs

0
Member Avatar LawfordCap (99.73) Submitted: 5/5/2009 3:45:02 PM : Outperform Start Price: $3.37 BIOS Score: -42.45

trend PS test

Recs

0
Member Avatar golfer03 (< 20) Submitted: 1/13/2009 10:16:35 PM : Outperform Start Price: $2.84 BIOS Score: -22.55

With upcoming changes with our Health System puts BIOS in the Catbird seat going forward…

Recs

0
Member Avatar killianxplay (29.02) Submitted: 9/10/2008 5:49:48 PM : Outperform Start Price: $2.75 BIOS Score: +56.33

under rated

Recs

0
Member Avatar biovestor (< 20) Submitted: 6/28/2008 6:28:04 AM : Outperform Start Price: $2.69 BIOS Score: +69.46

A specialty small/micro-cap pharmacy benefit manager in an industry group that is currently out of favor, but likely to rebound strongly or be acquired over the next year or so.

Recs

0
Member Avatar evillate (< 20) Submitted: 6/20/2008 10:40:35 PM : Outperform Start Price: $3.28 BIOS Score: +32.13

Will double my money with this EASY.

Recs

0
Member Avatar MFClobberMeSilly (74.11) Submitted: 11/14/2007 1:47:28 PM : Outperform Start Price: $9.35 BIOS Score: -78.18

9.43 100% return in 2 years

Recs

0
Member Avatar oystermighty (< 20) Submitted: 10/30/2007 3:41:43 PM : Outperform Start Price: $8.12 BIOS Score: -63.57

Excellent trend

Recs

0
Member Avatar mlkr (21.03) Submitted: 9/12/2007 12:10:45 AM : Outperform Start Price: $6.51 BIOS Score: -50.43

On move.. Good investment/traading stock..

Recs

0
Member Avatar GaTeek (< 20) Submitted: 5/3/2007 6:56:03 PM : Outperform Start Price: $3.51 BIOS Score: +35.98

Compare to major PBM performance, margins back during MIMS deal, post restructuring moves by management

Recs

0
Member Avatar pekl06a (< 20) Submitted: 1/21/2007 4:51:04 PM : Outperform Start Price: $3.74 BIOS Score: +16.40

undervalued medical play, with growth. Buyout possibility, or merge with Option Care(OPTN)

Results 1 - 20 of 22 : 1 2 Next »

Featured Broker Partners


Advertisement